Difference between revisions of "Team:BioMarvel"

 
(61 intermediate revisions by 2 users not shown)
Line 3: Line 3:
  
 
<body>
 
<body>
 +
<script type="text/javascript">
 +
 +
window.onload = function(){
 +
rotateBanner = setInterval(function(){
 +
var pos = document.getElementsByName("pos");
 +
var size = pos.length;
 +
for(var i = 0; i < size; i++) {
 +
if(pos[i].checked) {
 +
var m = i+1;
 +
if (m >= size) {
 +
m = 0;
 +
}
 +
pos[m].checked = true;
 +
pos[i].checked = false;
 +
break;
 +
}
 +
}
 +
}, 3600);
 +
}
 +
 +
 +
</script>
 +
 
<style>
 
<style>
 
*{margin:0;padding:0;}
 
*{margin:0;padding:0;}
Line 32: Line 55:
 
#slide li{float:left;width:33.333%;height:100%;}
 
#slide li{float:left;width:33.333%;height:100%;}
 
#slide li:nth-child(1){
 
#slide li:nth-child(1){
−
background-image: url(https://static.igem.org/mediawiki/2018/f/f0/T--Biomarvel--Banner1.png);
+
−
background-size: cover;
+
 
}
 
}
 
#slide li:nth-child(2){
 
#slide li:nth-child(2){
−
background-image: url(https://static.igem.org/mediawiki/2018/3/3f/T--Biomarvel--Banner2.png);
+
 
−
background-size: cover;
+
 
}
 
}
 
#slide li:nth-child(3){
 
#slide li:nth-child(3){
−
background-image: url(https://static.igem.org/mediawiki/2018/7/7f/T--Biomarvel--Banner3.png);
+
 
−
background-size: cover;
+
 
}
 
}
 
#slide input{display:none;}
 
#slide input{display:none;}
−
#slide label{display:inline-block;vertical-align:middle;width:10px;height:10px;border:2px solid #666;background:#fff;transition:0.3s;border-radius:50%;cursor:pointer;}
+
#slide label{display:inline-block;vertical-align:middle;width:15px;height:15px;border:2px solid #666;background:#fff;transition:0.3s;border-radius:50%;cursor:pointer;margin-left: : 5px;margin-right: 5px;}
 
#slide .pos{text-align:center;position:absolute;bottom:10px;left:0;width:100%;text-align:center;}
 
#slide .pos{text-align:center;position:absolute;bottom:10px;left:0;width:100%;text-align:center;}
 
#pos1:checked~ul{margin-left:0%;}
 
#pos1:checked~ul{margin-left:0%;}
Line 64: Line 84:
 
.youtubeBox{
 
.youtubeBox{
 
position: relative;
 
position: relative;
−
width: 100%
+
display: block;
 +
margin-left: auto;
 +
margin-right: auto;
 +
width: 94%
 
}
 
}
 
.youtubeBox:before{
 
.youtubeBox:before{
Line 73: Line 96:
 
.youtubeBoxbox{
 
.youtubeBoxbox{
 
position: absolute;
 
position: absolute;
 +
border: 2px solid black;
 
top: 0;
 
top: 0;
 
right: 0;
 
right: 0;
Line 85: Line 109:
 
<div class="mMainBox">
 
<div class="mMainBox">
 
<section id="mSection">
 
<section id="mSection">
−
<img class="myimg" src="https://static.igem.org/mediawiki/2018/1/18/T--Biomarvel--mainhome.jpg">
+
<a href="https://www.facebook.com/biomarvel.igem.9"><img class="myimg" src="https://static.igem.org/mediawiki/2018/1/18/T--Biomarvel--mainhome.jpg"></a>
 
</section>
 
</section>
 
<div class="slideBox">
 
<div class="slideBox">
Line 91: Line 115:
 
<div id="slide">
 
<div id="slide">
 
<input type="radio" name="pos" id="pos1" checked>
 
<input type="radio" name="pos" id="pos1" checked>
−
<input type="radio" name="pos" id="pos2">
+
<input type="radio" name="pos" id="pos2">
 
<input type="radio" name="pos" id="pos3">
 
<input type="radio" name="pos" id="pos3">
 
<ul>
 
<ul>
−
<li><a href="https://2018.igem.org/Team:BioMarvel/Project/Description"><div style="width: 100%; height: 85%;"></div></a></li>
+
<li><a href="https://2018.igem.org/Team:BioMarvel/WET_LAB/Experiments"><img src="https://static.igem.org/mediawiki/2018/f/f0/T--Biomarvel--Banner1.png" style="width: 100%; height: 100%"></a></li>
−
<li><a href="https://2018.igem.org/Team:BioMarvel/Public_Engagement"><div style="width: 100%; height: 85%;"></div></a></li>
+
<li><a href="https://2018.igem.org/Team:BioMarvel/Public_Engagement"><img src="https://static.igem.org/mediawiki/2018/7/76/T--Biomarvel--Banner2_1.png" style="width: 100%; height: 100%"></a></li>
−
<li><a href="https://2018.igem.org/Team:BioMarvel/Project/Description"><div style="width: 100%; height: 85%;"></div></a></li>
+
<li><a href="https://2018.igem.org/Team:BioMarvel/Project/Description"><img src="https://static.igem.org/mediawiki/2018/7/7f/T--Biomarvel--Banner3.png" style="width: 100%; height: 100%"></a></li>
 
</ul>
 
</ul>
−
<p class="pos">
+
<p class="pos" style="padding-top: 2em;padding-bottom: 1em; margin: 0;">
 
<label for="pos1"></label>
 
<label for="pos1"></label>
 
<label for="pos2"></label>
 
<label for="pos2"></label>
Line 108: Line 132:
 
<section id="mSection">
 
<section id="mSection">
 
<div class="mSHdiv">
 
<div class="mSHdiv">
−
<h1>ABSTRACT</h1>
+
<h1 style="color: white;padding-top: 8px; padding-bottom: 7px;">Abstract</h1>
 
</div>
 
</div>
 
<br>
 
<br>
 
<p>The goal of this project is to construct a novel fusion protein of gold binding polypeptides (GBP)-protein G (ProG) to develop an electrochemical biosensor for rapid and simple diagnosis and monitoring heart failure.</p>
 
<p>The goal of this project is to construct a novel fusion protein of gold binding polypeptides (GBP)-protein G (ProG) to develop an electrochemical biosensor for rapid and simple diagnosis and monitoring heart failure.</p>
−
<p>DH5-alpha E. coli strain was transformed by a genetically modified recombinant vector coding GBP and ProG. The GBP-ProG fusion protein was derived from the strain with IPTG-induced expression and purified using the TALON metal affinity resin. The resulting GBP-ProG was directly self-immobilized onto gold surfaces via the GBP portion, followed by the oriented binding of antibodies onto the ProG domain targeting the Fc region of antibodies.</p>
+
<p>DH5-alpha <i>E. coli</i> strain was transformed by a genetically modified recombinant vector coding GBP and ProG. The GBP-ProG fusion protein was derived from the strain with IPTG-induced expression and purified using the TALON metal affinity resin. The resulting GBP-ProG was directly self-immobilized onto gold surfaces via the GBP portion, followed by the oriented binding of antibodies onto the ProG domain targeting the Fc region of antibodies.</p>
−
<p>An electrochemical immunochip was fabricated through the GBP-ProG and gold patterned interdigitated array electrode. Antibody immobilization onto the gold surface of the electrode by the GBP-ProG was rapidly and simply achieved with proper antibody orientation. This immunochip shown in this study could be used for diagnosis and monitoring of heart failure.</p>
+
<p>An electrochemical immunochip was fabricated through the GBP-ProG and gold patterned interdigitated array electrode. Antibody immobilization onto the gold surface of the electrode by the GBP-ProG was rapidly and simply achieved with proper antibody orientation. This immunochip could be used for diagnosis and monitoring of heart failure.</p>
 
</section>
 
</section>
 
<br>
 
<br>
Line 119: Line 143:
 
<section id="mSection">
 
<section id="mSection">
 
<div class="mSHdiv">
 
<div class="mSHdiv">
−
<h1>U-HEALTHCARE SERVICE SYSTEM</h1>
+
<h1 style="color: white;padding-top: 8px; padding-bottom: 7px;">U-HEALTHCARE SERVICE SYSTEM</h1>
 
</div>
 
</div>
 +
<video class="myVideo" src="https://static.igem.org/mediawiki/2018/6/63/T--Biomarvel--Ubiquitous_System.mp4" muted="muted" controls="" autoplay="autoplay" loop="loop"></video>
 
<br>
 
<br>
−
<p></p>
+
 
−
<br>
+
<!--
−
<img class="myimg" src="https://static.igem.org/mediawiki/2018/a/a1/T--Biomarvel--uhealth.jpg">
+
<h1 style="text-align: center; text-shadow: 2px 2px 3px gray;">Ubiquitous System for Diagnosis and Monitoring of Heart Failure</h1>
−
<br>
+
-->
 
<br>
 
<br>
−
<a href="https://2018.igem.org/Team:BioMarvel/People/Team"><img class="myimg" src="https://static.igem.org/mediawiki/2018/d/d8/T--Biomarvel--mainhome2.jpg"></a>
+
<a href="https://2018.igem.org/Team:BioMarvel/People/Team"><img class="myimg" src="https://static.igem.org/mediawiki/2018/2/27/T--Biomarvel--mainhome2_1.png"></a>
 
</section>
 
</section>
 
<br>
 
<br>
Line 134: Line 159:
 
<div class="youtubeBox">
 
<div class="youtubeBox">
 
<div class="youtubeBoxbox">
 
<div class="youtubeBoxbox">
−
<iframe width="100%" height="100%" src="https://www.youtube.com/embed/" frameborder="0" allow="autoplay; encrypted-media" allowfullscreen></iframe>
+
<iframe width="100%" height="100%" src="https://www.youtube.com/embed/URUYaF4gsQ4" frameborder="0" allow="autoplay; encrypted-media" allowfullscreen></iframe>
 
</div>
 
</div>
 
</div>
 
</div>

Latest revision as of 23:28, 6 December 2018

≡

Abstract


The goal of this project is to construct a novel fusion protein of gold binding polypeptides (GBP)-protein G (ProG) to develop an electrochemical biosensor for rapid and simple diagnosis and monitoring heart failure.

DH5-alpha E. coli strain was transformed by a genetically modified recombinant vector coding GBP and ProG. The GBP-ProG fusion protein was derived from the strain with IPTG-induced expression and purified using the TALON metal affinity resin. The resulting GBP-ProG was directly self-immobilized onto gold surfaces via the GBP portion, followed by the oriented binding of antibodies onto the ProG domain targeting the Fc region of antibodies.

An electrochemical immunochip was fabricated through the GBP-ProG and gold patterned interdigitated array electrode. Antibody immobilization onto the gold surface of the electrode by the GBP-ProG was rapidly and simply achieved with proper antibody orientation. This immunochip could be used for diagnosis and monitoring of heart failure.


U-HEALTHCARE SERVICE SYSTEM




#iGEM #2018 #BioMarvel #Heart #Biochip #Diagnosis

Contact Us !

IGEM2018BioMarvel@gmail.com

Copyright © 2018 By BioMarvel. All right reserved.